• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Cognitive Behavioural Therapy May Lead To Brain Changes in Adolescents With Anxiety Disorders

byUsamah BhaiduandFlaviu Trifoi
March 11, 2024
in Psychiatry, Wellness
Reading Time: 2 mins read
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Share on FacebookShare on TwitterShare on LinkedIn

1. Cognitive behavioural therapy (CBT) showed reduced activation in specific areas of the brain of adolescents with an anxiety disorder post-treatment.

2. Activation in these areas remained stable in adolescents at risk for AD not receiving CBT, supporting the neural response to cognitive behavioural therapy.

Evidence Rating Level: 1 (Excellent)

Approximately 31.9% of adolescents are affected by anxiety disorders (AD). Cognitive behavioural therapy (CBT) has proven to be an effective treatment for AD and remains the first-line treatment in clinical practice. The neural changes in the brain associated with CBT however have not been studied well.

This randomized control trial investigated the effects of CBT on the brains of adolescents with an AD by having participants complete threat processing tasks (TPT) during fMRI pre and post-CBT treatment. The dot-probe task was used as the TPT. Sixty-nine participants with an AD were compared to a control group of 62 participants without an AD. Additionally, 87 participants at risk for AD were also included to track the stability of neural activation without CBT over time. Participants between the ages of 8-17 with an IQ over 70, proficient in the English language, who had a confirmed diagnosis of an AD (general AD, social AD, separation AD) by semi-structured interview were included. Participants with any serious medical/psychiatric condition, suicidal ideation, substance abuse, or trauma history were excluded. The treatment group received 12 sessions of CBT. Participants were assessed weekly for clinical improvement using the pediatric anxiety scale and the clinical global impressions scale. The primary outcome measured changes to neural activation post-CBT treatment in adolescents with an AD.

Compared to the control group, fMRI data showed comparable or reduced activation in the fronto-parietal regions in the treatment group. Associated regions which included the temporal gyri, the inferior parietal lobules, and the middle occipital gyrus also showed reduced activation. Stability in these areas was seen in the at-risk group supporting treatment response to CBT. No effect was appreciated in the motor cortex, the right amygdala, or the lateral anterior frontal areas. These areas showed hyperactivation pre and post-treatment. A limitation of this study is that a large proportion of participants came from high-income households. It is important to keep in mind that these individuals may have access to resources that complement treatment that their low SES counterparts do not have. This may confound results by overestimating the effects of CBT alone on neural activation. Nevertheless, this study demonstrates important neural changes associated with CBT in specific areas of the brain of adolescents with ADs. Future research may contribute to tailoring CBT to target these areas specifically.

RELATED REPORTS

Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

Click here to read this study in The American Journal of Psychiatry.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietyCBTcognitive therapymental health
Previous Post

2 Minute Medicine Rewind March 11, 2024

Next Post

Tenecteplase is equivalent to placebo between 4.5 and 24 hours after stroke onset

RelatedReports

A woman engages with a mental health app on her phone, while another woman provides support. The image symbolizes the connection between technology and mental well-being.
Artificial Intelligence

Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users

October 15, 2026
A young boy studying at a desk with books and a contrasting image of an adult man walking outdoors, symbolizing the life course from childhood to adulthood.
Pediatrics

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

October 14, 2026
An illustration depicting telemedicine services connecting two hospitals through a digital interface, emphasizing interhospital transfer and remote healthcare delivery.
Chronic Disease

Video mental health care may have clinical advantages versus phone or in-person visits

September 12, 2026
A man sits pensively by a window with a depiction of a synapse illustrating neurotransmitter activity, suggesting a focus on mental health treatment mechanisms.
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Next Post
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Tenecteplase is equivalent to placebo between 4.5 and 24 hours after stroke onset

#VisualAbstract: Enfortumab Vedotin and Pembrolizumab Reduces Mortality in Metastatic Urothelial Carcinoma

#VisualAbstract: Enfortumab Vedotin and Pembrolizumab Reduces Mortality in Metastatic Urothelial Carcinoma

Seladelpar improves symptoms of primary biliary cholangitis

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation
  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓EvidencePulse™ Deep research reports
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.